Acitretin

CHEMBL1131 Phase 4 Onaylandı Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
326.4 g/mol
LogP
6.1
Phase
4

An oral retinoid medication derived from vitamin A that is used to treat severe psoriasis and other serious skin disorders by regulating abnormal skin cell growth and reducing inflammation. It is highly effective for pustular and erythrodermic psoriasis but requires strict pregnancy prevention because it causes severe birth defects; women must avoid pregnancy for three years after stopping treatment. Regular blood tests to monitor liver function and blood lipid levels are essential during therapy.

Moleküler Ağırlık

326,4000 g/mol

LogP

6,10

TPSA

46,50 Ų

Lipinski RO5

Geçer

Terapötik Alanlar

Etki Mekanizması

Serves as an essential micronutrient cofactor in various enzymatic reactions and metabolic processes. Supplementation corrects deficiency states and supports normal physiological function.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mekanizma

Serves as an essential micronutrient cofactor in various enzymatic reactions and metabolic processes. Supplementation corrects deficiency states and supports normal physiological function.

2D Yapı

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

COc1cc(C)c(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)c(C)c1C

InChI

InChI=1S/C21H26O3/c1-14(8-7-9-15(2)12-21(22)23)10-11-19-16(3)13-20(24-6)18(5)17(19)4/h7-13H,1-6H3,(H,22,23)/b9-7+,11-10+,14-8+,15-12+

Molecular Formula

C21H26O3

HBD / HBA

1 / 3

Döndürülebilir Bağlar

6

Ağır Atomlar

24

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

An oral retinoid medication derived from vitamin A that is used to treat severe psoriasis and other serious skin disorders by regulating abnormal skin cell growth and reducing inflammation. It is highly effective for pustular and erythrodermic psoriasis but requires strict pregnancy prevention because it causes severe birth defects; women must avoid pregnancy for three years after stopping treatment. Regular blood tests to monitor liver function and blood lipid levels are essential during therapy.

Serves as an essential micronutrient cofactor in various enzymatic reactions and metabolic processes. Supplementation corrects deficiency states and supports normal physiological function.

Yes, Acitretin is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1131. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 5284513. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.